Hyperuricemia
📧 Sign up to get email alerts when something new happens for Hyperuricemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Effect of Chrysanthemum Flower Oil and Its Dose-dependency on Hyperuricemia [NA]
A completed clinical trial assessing whether chrysanthemum flower oil has a dose-dependent effect on hyperuricemia.
-
FDA approval · 2016-07-28FDA Approved: ALLOPURINOL — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original (generic) application for allopurinol from Heritage Pharmaceuticals Inc. (d/b/a Avet Pharmaceuticals Inc.).
-
FDA approval · 2015-11-13FDA Approved: ALLOPURINOL — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Allopurinol from Actavis Pharma, Inc. (NDA018877).
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Phase II Exploratory Clinical Study of KUX-1151 [Phase 2]
A Phase II exploratory study of KUX-1151 by Kissei Pharmaceutical for hyperuricemia has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-12Clinical Trial Update: A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of RDEA3170 with febuxostat for gout and asymptomatic hyperuricemia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Effect of Reducing Uric Acid on Insulin Sensitivity and Oxidative Status [NA]
Completed clinical trial investigating whether reducing uric acid improves insulin sensitivity and oxidative status in obesity/metabolic syn…
-
FDA approval · 2015-05-13FDA Approved: ALOPRIM — Supplemental Application (Mylan Institutional LLC)
The FDA approved a supplemental application for ALOPRIM (allopurinol) submitted by Mylan Institutional LLC, resulting in updated labeling.
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout [Phase 2]
Phase 2 trial update reporting safety and efficacy findings for MBX-102 in treating hyperuricemia in patients with gout.
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout [Phase 2]
Phase 2 trial update reporting pharmacokinetics, pharmacodynamics, and safety of combining arhalofenate with febuxostat in patients with gou…
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients [Phase 2]
Open-label Phase 2 safety and efficacy study of combining arhalofenate with febuxostat for hyperuricemia and gout has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Effect of Quercetin Supplements on Healthy Males: a Four-Week Randomized Cross-Over Trial [EARLY_Phase 1]
A four-week randomized cross-over Phase 1 trial evaluated the effects of quercetin supplements in healthy male participants and has complete…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Study of FYU-981 in Hyperuricemia With or Without Gout [Phase 2]
Phase 2 clinical trial evaluating FYU-981 for hyperuricemia with or without gout has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Safety and Efficacy of TULY (Rasburicase) in Prevention and Treatment of Malignancy-associated Hyperuricemia [Phase 3]
Phase 3 trial evaluating the safety and efficacy of rasburicase (TULY) for prevention and treatment of malignancy-associated hyperuricemia h…
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels [Phase 2]
Phase 2 trial evaluating allopurinol for symptom relief in patients with heart failure and elevated serum uric acid.
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout [Phase 2]
Phase 2 trial update assessing the effect of febuxostat on joint damage in hyperuricemic subjects with early gout; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Hyperuricemia on Hypertension and Metabolic Syndrome [Phase 2]
Phase 2 clinical trial update on the impact of hyperuricemia on blood pressure and metabolic syndrome parameters, with completed status and …
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Rasburicase (Fasturtec) Registration Trial [Phase 3]
Phase 3 Rasburicase registration trial (Fasturtec) for hyperuricemia was terminated.
-
CLINICAL_TRIALS research · 2014-04-14Clinical Trial Update: The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome
A clinical trial update investigating whether antiphospholipid antibodies affect the relationship between hyperuricemia, gout, and metabolic…
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Gout Dose Response Study [Phase 2]
Phase II gout dose-response trial completed; the study sponsored by Ardea Biosciences focused on hyperuricemia.
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout [Phase 2]
Phase 2 clinical trial evaluating RDEA806 in hyperuricemic subjects with symptomatic gout has completed.
-
FDA approval · 2013-12-12FDA Approved: ULORIC — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ULORIC (febuxostat) by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Effect of Allopurinol Treatment on Insulin Resistance [NA]
This clinical trial update assesses the effect of allopurinol treatment on insulin resistance in individuals with hyperuricemia and prediabe…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency [Phase 2]
A completed Phase 2 randomized, double-blind dose–response study evaluated the safety and uric acid–lowering effects of oral ulodesine added…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to Allopurinol [Phase 2]
A Phase 2 trial evaluating the uric acid-lowering activity, safety, and efficacy of adding ulodesine to allopurinol in patients with gout an…
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: Impact of Blueberries on Uric Acid and Quality of Life [NA]
A completed study evaluated whether blueberry consumption affects uric acid levels and quality of life in individuals with hyperuricemia.